Treatment success rate for patients treated for MDR-TB in Poland

Poland: Treatment success rate for patients treated for MDR-TB was 23.0% in 2016. ▼ Falling

Latest (2016)
23.0%
Change on year
down 28.1%
World rank
156th
of 163 countries
All-time high
59.0%
in 2007
All-time low
13.0%
in 2012
Years of data
11
2006–2016

Treatment success rate for patients treated for MDR-TB in Poland, 2006–2016

1020304050602006201120162006: 442007: 592008: 472009: 572010: 502011: 352012: 132013: 222014: 182015: 322016: 23

Source: World Health Organization, Global Health Observatory.

Analysis

Poland recorded 23.0% for treatment success rate for patients treated for mdr-tb in 2016.

The figure is down 28.1% on the previous year and down 47.7% over ten years.

Over the whole period, treatment success rate for patients treated for mdr-tb in Poland peaked at 59.0% in 2007 and was at its lowest, 13.0%, in 2012.

That places Poland 156th out of 163 countries with data for 2016, putting it in the bottom quarter.

The long-run direction has been consistently falling across the 11 years of available data.

Treatment success rate for patients treated for MDR-TB in Poland, year by year

Annual values for Treatment success rate for patients treated for MDR-TB (%) in Poland, 2006 to 2016.
Year Value Change
2006 44.0%
2007 59.0% +34.1%
2008 47.0% -20.3%
2009 57.0% +21.3%
2010 50.0% -12.3%
2011 35.0% -30.0%
2012 13.0% -62.9%
2013 22.0% +69.2%
2014 18.0% -18.2%
2015 32.0% +77.8%
2016 23.0% -28.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 51.8% 44.0% 59.0% 4
2010s 27.6% 13.0% 50.0% 7

Countries ranked near Poland

  1. 155 Ireland 27.0% compare
  2. 157 Bahrain 17.0% compare
  3. 158 France 3.0%
  4. 159 Latvia 0.0% compare
  5. 159 Maldives 0.0% compare
  6. 159 Oman 0.0% compare
  7. 159 Angola 0.0% compare
  8. 159 Marshall Islands 0.0% compare

See the full ranking of 175 places →

More health data for Poland

All data for Poland →

Frequently asked questions

What is treatment success rate for patients treated for mdr-tb in Poland?
Treatment success rate for patients treated for mdr-tb in Poland was 23.0% in 2016, according to World Health Organization, Global Health Observatory.
What is the highest treatment success rate for patients treated for mdr-tb recorded in Poland?
The highest recorded value was 59.0% in 2007.
What is the lowest treatment success rate for patients treated for mdr-tb recorded in Poland?
The lowest recorded value was 13.0% in 2012.
How does Poland rank for treatment success rate for patients treated for mdr-tb?
Poland ranks 156th out of 163 countries with data for 2016.
Is treatment success rate for patients treated for mdr-tb rising or falling in Poland?
Over the last ten years it is down 47.7%. The long-run trend across the full record is falling.
Where does this Poland data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Treatment success rate for patients treated for MDR-TB in Poland. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 September 2026, from https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/poland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/poland/">Treatment success rate for patients treated for MDR-TB in Poland</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed